Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
May 31, 2018
Aug. 31, 2017
Current    
Cash and cash equivalents $ 2,063,369 $ 2,533,337
Marketable securities 17,617 0
Accounts and other receivable 267,777 45,293
Inventory 76,475 67,174
Prepaid expenses 161,882 149,691
Total Current Assets 2,587,120 2,795,495
Patents 120,567 62,827
Equipment 1,392 1,856
Total Noncurrent Assets 121,959 64,683
TOTAL ASSETS 2,709,079 2,860,178
Current    
Accounts payable and accrued liabilities 62,533 32,574
Unearned revenue 0 17,083
Due to related parties 9,110 42,690
Total Current Liabilities 71,643 92,347
TOTAL LIABILITIES 71,643 92,347
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 72,397,305 common shares at May 31, 2018 and 67,975,761 common shares at August 31, 2017 72,397 67,976
Shares to be issued 500 0
Additional paid-in capital 21,123,864 16,108,270
Accumulated other comprehensive income (7,383) 0
Deficit (18,551,942) (13,169,939)
Equity attributable to shareholders of the Company 2,637,436 3,006,307
Non-Controlling Interest 0 (238,476)
Total Stockholders' Equity 2,637,436 2,767,831
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,709,079 $ 2,860,178